7-Boc-1-oxo-2,7-diazaspiro[3.5]nonane, 95.0%, 500mg

1,1,1,3,3,3-Hexafluoro-2-propanol (HFIP) , 25mL, >=99%, for peptide synthesis

3-Butynoic acid, 98.0%, 10g

3,5-Difluoro-2-methoxybenzoic acid, 95.0%, 500mg

6-((2-(2,6-DIOXOPIPERIDIN-3-YL)-1,3-DIOXOISOINDOLIN-4-YL)AMINO)HEXANOIC ACID, 95%, 100mg

Methyl 3-cyano-3-methylbutanoate, 97%, 100mg

Dibenzofuran-4-ylmethyl-isopropyl-amine hydrochloride, 1g

2-(2,5-DIOXOPYRROLIDIN-1-YL)ETHYL METHYL FUMARATE, 95.0%, 50mg

3-Chloro-4-iodopyridine>98.0%(GC)(T)1g

1,3-Propanesultone>99.0%(GC)500g

SPIRO[INDENE-1,4'-PIPERIDINE]-3-CARBOXYLIC ACID, 95%, 100mg

1-(5-amino-2-methylphenyl)-2-pyrrolidinone, 95.0%, 5g

(S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)(methyl)amino)-4-oxo-4-(tritylamino)butanoic acid, 97%, 1g